EAST MIDLANDS OPERATIONAL OVERSIGHT GROUP (OOG) MINUTES OF THE BOARD MEETING HELD ON FRIDAY 11 MAY 2012 FOSSE HOUSE BOARD ROOM, NHS LEICESTER CITY COUNTY & RUTLAND Item Discussion Action by Present Martin McShane (Chair), NHS Lincolnshire Lee Bartholomew, Lay Member, Specialised Commissioning Group Hanna Blackledge, NHS Leicester City, Leicestershire County and Rutland/Public Health Anthony Chapman, NHS Leicester City, Leicestershire County and Rutland Julia Cons, Lay Member, Specialised Commissioning Group Mary Corcoran, NHS Nottingham City & County, NHS Bassetlaw Andy Leary, NHS Derbyshire Gill Scoular, NHS Milton Keynes and NHS Northamptonshire, Midlands and East Specialised Commissioning Group In Attendance, Midlands and East Specialised Commissioning Group Peter Davies, Midlands and East Specialised Commissioning Group David Giffard, Midlands and East Specialised Commissioning Group Julia Grace, Midlands and East Specialised Commissioning Group Rob Lusuardi, Midlands and East Specialised Commissioning Group Malcolm Qualie, Midlands and East Specialised Commissioning Group Ruth Sargent, Midlands and East Specialised Commissioning Group Tina Starling, Midlands and East Specialised Commissioning Group East of England Apologies Catherine Griffiths (Chair) David Black, NHS Derbyshire (represented by Andy Leary Tim Daniel, LLR/Public Health (represented by Hanna Blackledge) Donna Hakes, Midlands and East Specialised Commissioning Group Chris Kenny, NHS Nottingham City & County, NHS Bassetlaw (represented by Mary Corcoran) David Sharpe, NHS Derbyshire (represented by Andy Leary) Vikki Taylor, NHS Leicestershire City, Leicestershire County and Rutland (represented by Anthony Chapman) 1
Register of interests and declaration of interests for items on the agenda None received Minutes of the previous meeting held on 9 March 2012 Actions from the previous meeting held on 9 March 2012 2. Directors Report 3. Corporate Issues 3.1 Draft Objectives 3.2 Clinical Reference Groups The minutes from the meeting held on 9 March 2012 were formally agreed and accepted. to issue an invite to attend/observe SCG OOG meetings to Clinical Commissioning Groups via group members. was in discussion with clinical staff at Milton Keynes to understand and resolve haemaglobinopathy service issues. All other actions had been completed. Establishment Agreement This had been endorsed by all East Midlands PCTs. Children s Congenital Heart A final decision was to be made by the Joint Committee of PCTs at a public meeting on 4 July. All PCT s had been asked to carry out an Equality Impact Assessment and responses logged with the JCPCT secretariat before 6 June 2012. Transfer of full contract documentation for all acute and mental health contracts held on behalf of Milton Keynes PCT was still awaited. Timeline for completion was 1 st June. A meeting was to be arranged with, Simon Jupp and Gill Scoular to escalate issues as necessary. The paper summarised the top level objectives for the EMSCT for 2012/13. It was agreed to circulate QIPP schemes for respective clusters. Discussion took place with regard to capacity within the team if priorities were to change. was to provide a risk assessment chart for the next meeting. The Group approved the objectives for 2012/13. The report updated the Group on the establishment of Clinical Reference Groups (CRGs). The paper A Guide to Specialised Services Clinical Reference Groups had been forwarded electronically for information and hard copies of the report were made available at the meeting. The Group noted the report and supported the ongoing work with CRGs. All PCTs Pete Davies 2
4. Operational Performance 4.1 2011/12 Finance and Performance Report The OOG were asked to receive month 12 financial and performance report for specialised expenditure (year end). The outturn position for specialised expenditure was 1.81m underspent. The actual outturn was 1.8m less than forecast mainly because the marginal rate adjustment for NUH was taken through the Nottinghamshire Cluster books directly, rather than through the SCG position. Additional QIPP schemes had been identified to ensure overall balanced financial position. Overall delivery of 19.03m against 13.4m target. The Group approved the use of the carried forward resource as detailed below to address in year issues: IVAN Trial Medium Secure Cochlear Implants Scoliosis Spinal Vent Beds Fertility TAVI 500k Lucentis V Avastin trial costs 500k Pump priming QIPP initiative 200k Scheme to address waiting list 800k Scheme to address waiting list 200k Scheme to address STH bed pressures 200k IVF activity pressures 300k Out of Area treatments Formal thanks were given to the team for performance, finance and quality. It was agreed that would provide a short brief on improved value as a message to Cluster Boards and Clinical Commissioning Groups. The Group approved the report. 4.2 Financial Accounting Close The report provided an update on key issues affecting the final accounts. 4.3 Monthly Update East Midlands Cancer Drug Fund 4.4 Acute Services Neonatal Update on Performance Issues The Group received the report and noted the supplementary guidance. The report provided an update on the final position of the 2011/12 Cancer Drug Fund applications received and provided an overview of the arrangements for 2012/13. The Group received the update. The report provided an update on the work being undertaken with the neonatal units of United Lincolnshire Hospitals (ULHT) and Northampton General Hospital (NGH). ULHT An external review has been commissioned The Trust continue to work to the revised clinical thresholds until the conclusion of the review is known The Trust will meet with EMSCG in May in order to provide full assurance against the action plan 3
NGH An action plan was to be developed by the Trust based on the external review Thresholds are in place for babies below 27 weeks gestation The Group received the report. 4.5 Mental Health The report provided an update on current progress and developments within Mental Health Commissioning. 5. Planning 2012/13 5.1 Contract Status Report The Group received the report and noted the progress made. Formal thanks were given. The report provided an update on the status of the 2012/13 contract portfolio. It was noted that all contracts bar one had been agreed and financial assumptions for the EMSCG contract portfolio had been shared with finance leads across the PCTs. The Group received the report and supported the recommendations. 5.2 Major Trauma Update The report provided an update on the progress in implementing Trauma Networks in accordance with the Operating Framework and provided proposals for ongoing accountability and management of the implementation. The Group received the update and agreed the following recommendations: To approve the proposed Accountability Structure for the implementation of the Trauma Implementation. To support the proposals to establish a Midlands and East Cluster Trauma System Board To act as the accountable body and to receive progress reports at subsequent OOG meetings To approve the additional funding for a project manager for a period of six months ( 32,000) To note the contract agreement and outcome of the assurance process accrediting NUH as the Major Trauma Centre Andy Leary stated that he was unaware of all the specific issues for Derbyshire. 5.3 Medicine Procurement/QIPP Plan for 2012/13 The report provided details of medicine procurement projects and the QIPP savings plan for 2012/13. The savings forecast for 2012/3 was 2,642,864 and the potential for further savings opportunities following the conclusion of procurement exercises were noted. It was agreed to forward to members an electronic copy of the Medicine Procurement Financial Summary providing specific details to individual Trusts. Malcolm Qualie 4
The Group received the update and acknowledged and supported the continued work of the Pharmacy Collaborative in delivering savings. The Group supported the ICD tendering project. 6. Governance It was noted that non-medicine procurement would be an agenda item at the next OOG. 6.1 Risk Register The Group received the operational 2011/12 risk register and acknowledged the risks identified. The main risks identified were: Neonatal Services at Northampton General and United Lincoln Hospitals Children s Cardiac Review (to be included as an agenda at the June OOG) Ivacaftor (targeted treatment for a particular sub-group of cystic fibrosis patients) It was agreed to include an additional risk regarding the impact of bowel cancer screening on radiotherapy. Mary Corcoran informed the group that endoscopy data would be available by the end of June. to liaise with the Cancer Network to identify the risk. 7. Policies 7.1 NICE Guidance update The report submitted to the OOG provided an update on the development in NICE Guidelines relevant to specialised services. The Group received the update report. 7.2 Stereotactic Body Radiotherapy in the treatment of Lung Cancer 8. Further Matters to note The Group approved the evaluation of Stereotactic Body Radiotherapy in the treatment of Lung Cancer. Quarterly reports to be received by the OOG. 8.1 Neuromuscular Network The Group approved the Neuromuscular Network Terms of Reference, Aims and Objectives and the 2012/13 work programme. 8.2 Mental Health and Learning Disability Board Minutes The OOG received and accepted the draft minutes from the meeting held in March 2012. 8.3 LLR Audit Committee Extract from Minutes The OOG received and accepted the extract from LLR Audit Committee minutes from the meeting held in January 2012. 5
9. Date, time and Venue of the next Meeting Friday, 22 June at 10.00 a.m. in Fosse House Board Room 6